A detailed history of Smartleaf Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 2,223 shares of VRTX stock, worth $1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,223
Previous 1,660 33.92%
Holding current value
$1 Million
Previous $785 Million 31.15%
% of portfolio
0.12%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $258,980 - $284,754
563 Added 33.92%
2,223 $1.03 Billion
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $139,054 - $171,877
354 Added 27.11%
1,660 $785 Million
Q1 2024

Oct 07, 2024

SELL
$407.69 - $446.08 $144,322 - $157,912
-354 Reduced 21.33%
1,306 $545 Million
Q1 2024

May 02, 2024

BUY
$407.69 - $446.08 $175,714 - $192,260
431 Added 49.26%
1,306 $403 Million
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $300,125 - $359,345
875 New
875 $356 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.